Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02841553 · ClinicalTrials.gov registry record
Wolfram Syndrome and WFS1-related Disorders International Registry and Clinical Study
A clinical trial of Diabetes Mellitus and Deafness, sponsored by Washington University School of Medicine.
- Recruiting
- Registry status
- 5,000
- Enrollment target
- 1
- Study location
NCT02841553 is a study of Diabetes Mellitus and Deafness that is actively recruiting participants, run by Washington University School of Medicine. The registered enrollment target is 5,000 participants, above the 1,843-participant average among 208 other Diabetes Mellitus trials with a reported enrollment target (171% higher). The trial reports 1 study location across 1 state.
The verdict
NCT02841553, a study of Diabetes Mellitus and Deafness, is actively recruiting participants, sponsored by Washington University School of Medicine.
- RECRUITING
- Registry status
- 5,000 participants
- Enrollment target
- 1
- Study location
Study Summary
In this study, the investigators hypothesize that studying monogenic variants with strong effect associated with severe insulin deficiency of Wolfram syndrome will provide important insights into the more complex type 1 and type 2 diabetes mellitus. Aim 1. Establish and maintain a registry of patients with Wolfram syndrome. An Internet based registry will be employed to enroll participants with the clinical diagnosis of Wolfram syndrome (insulin dependent DM and bilateral OA). Clinical information regarding age of diagnosis and progression of the disease will be collated and analyzed to better define its natural history, along with potential metabolic phenotypes such as glucose intolerance of heterozygous parents and unaffected sibs. If not already completed, blood for WFS1 sequence analysis will be obtained on the participants (parents and sibs also for control purposes) and sent to a CLIA certified lab to define the mutation. This information will benefit patient families and referring physicians by providing a genetic diagnosis and where indicated. The Wolfram Syndrome Registry will foster international collaborations to more efficiently and systematically collect Wolfram syndrome patients and their clinical and experimental data.
Conditions Studied
Study Locations (1)
Missouri
- Washington University School of Medicine - St Louis
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 5,000 participants |
| Start Date | 2011-07 |
| Est. Completion | 2027-04 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02841553
The ClinicalTrials.gov registry entry for NCT02841553 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 5,000 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 1,843-participant average among 208 other Diabetes Mellitus trials with a reported enrollment target (171% higher). The listed sponsor is Washington University School of Medicine, which has 1,502 total studies on file at ClinicalTrials.gov.
The record links to 6 conditions, with Diabetes Mellitus appearing as the primary indexed condition, and to 0 interventions.
NCT02841553 reports 1 study location spanning 1 distinct geographic area - top geographies include Missouri.
Frequently Asked Questions
What is clinical trial NCT02841553 about?
NCT02841553 is a clinical study titled "Wolfram Syndrome and WFS1-related Disorders International Registry and Clinical Study". In this study, the investigators hypothesize that studying monogenic variants with strong effect associated with severe insulin deficiency of Wolfram syndrome will provide important insights into the more complex type 1 and type 2 diabetes mellitus. Aim 1. Establish and maintain a registry of patie...
What is the current status of trial NCT02841553?
This trial is currently recruiting. The enrollment target is 5,000 participants. The study started on 2011-07. Estimated completion is 2027-04.
What conditions does trial NCT02841553 study?
This clinical trial studies the following conditions: Diabetes Mellitus, Deafness, Ataxia, Diabetes Insipidus, Wolfram Syndrome.
Who is sponsoring clinical trial NCT02841553?
This trial is sponsored by Washington University School of Medicine, which has 1,502 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02841553 being conducted?
This trial has 1 study location across Missouri. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Diabetes Mellitus
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Genetic Studies of Insulin and Diabetes
RECRUITING
-
Improving Glycemic Control With Telemedicine and Smart Insulin Pens
RECRUITING · NA
-
Family Investigation of Nephropathy and Diabetes (F.I.N.D.)
RECRUITING
-
Genetics Of Autoimmunity In Type I Diabetes
RECRUITING
-
Comparing Healthcare Visit Recording and Open Notes to Improve Chronic iLlness Care Experience in Older Adults
RECRUITING · NA
-
Therapeutic Plantar Electrical Stimulation Intervention During Hemodialysis to Improve Balance and Mobility
RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.